Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

The Ocular Surface Volume 29, July 2023, Pages 537-546 Stephanie L. Watson, Lyndon W. Jones, Fiona Stapleton, Mark Hinds, Alison Ng, Jacqueline Tan, Yair Alster, Charles Bosworth, Omer Rafaeli, Venita DePuy, The CELESTIAL STUDY Group Over the past few years our own, Mark Hinds, with his team at Ophthalmic Trials Australia (www.ot-au.com) have been involved in the multi-centered investigation into the efficacy and safety of selenium sulfide ointment in the setting of meibomian gland dysfunction (MGD)… Continue reading Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

MiYOSMART Spectacle Lenses for Myopia Control

The MiYOSMART spectacle lenses have been found to significantly reduce the progression of myopia and axial elongation in children in the UK, as compared to data from untreated myopes. The study looked at the change in spherical equivalent refraction (SER) and axial length (AL) over a period of 12 months in 87 children between the… Continue reading MiYOSMART Spectacle Lenses for Myopia Control

Myopia in Australian kids – an easy read

Myopia, commonly known as nearsightedness, is a growing concern in Australia, especially in children. Myopia occurs when the eye is longer than normal, causing light to focus in front of the retina instead of on it, leading to blurred vision. This can lead to a range of problems, such as difficulty reading or seeing distant… Continue reading Myopia in Australian kids – an easy read

Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops

ARVO Abstract Number: 812 – C0495 AuthorBlock: Matilda Biba1, Gareth Lingham1, Emmanuel Kobia-Acquah1, Ian Flitcroft1,2, James Loughman1 1Centre for Eye Research Ireland (CERI), Technological University Dublin, Dublin, Dublin, Ireland; 2Ophthalmology, Children’s Health Ireland at Temple Street, Dublin, Dublin, Ireland; Summary of paper : Myopia, also known as near sightedness, is a condition where a person can see nearby… Continue reading Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops

The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication

AZR-MD-001 restores gland gunction and improves signs and ocular symptoms of mebomian gland dysfunction (MGD) Posterboard#: B0072 Abstract Number: 5175 – B0072 AuthorBlock: Preeya Gupta1,2, Laura Elizabeth Downie3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Triangle Eye Consultants, Raleigh, North Carolina, United States; 2Ophthalmology, Tulane University, New Orleans, Louisiana, United States; 3Optometry and Vision Science, The University of Melbourne, Melbourne,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication

The Association for Research in Vision and Ophthalmology (ARVO 2023) – Publication.

AZR-MD-001 efficacy in resolving the signs and associated symptoms of meibomian gland dysfunction (MGD) in a phase 2 trial: responder status analysis Posterboard#: B0026 Abstract Number: 5129 – B0026 AuthorBlock: Lisa Nijm1,2, Jennifer P. Craig3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Warrenville EyeCare & LASIK, Chicago, Illinois, United States; 2Ophthalmology, University of illinois Eye and Ear Infirmary, Chicago,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) – Publication.

Atropine Dosage in Australian Population

Atropine Dosage in Australian Population – April 2023 – Myopia Profile Update AbstractTitle: Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trialAuthors: Samantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska, Paul G Sanfilippo, Adrian Koay, Maria Franchina, Audrey Chia, James Loughman, Daniel Ian Flitcroft, Christopher J Hammond, Augusto… Continue reading Atropine Dosage in Australian Population

Coastrek Sunshine Coast 2018 – Foxy Oxies – Fred Hollows Foundation

Trace is out today after months of preparation and fundraising for Fred Hollows Foundation running like the wind blows! Good luck ladies!   More than 1000 trekkers are gearing up for this year’s Wild Women On Top Sunshine Coastrek, which raises funds for The Fred Hollows Foundation’s work to end avoidable blindness. They’re also raising… Continue reading Coastrek Sunshine Coast 2018 – Foxy Oxies – Fred Hollows Foundation

Acuvue Oasys One Day For Astigmatism – pre-release.. oh yeah!

We have this NOW! Due to hit (the rest of) Australia in 2018 with around the clock axis for astigmatism.  If you have not been able to be fit with soft daily disposable contact lenses due to not being available those miserable days might be at an end. ACUVUE OASYS® 1-DAY for ASTIGMATISM is designed… Continue reading Acuvue Oasys One Day For Astigmatism – pre-release.. oh yeah!